The store will not work correctly when cookies are disabled.
3,5-dichloro-N-[3-chloro-4-(4-hydroxyphenoxy)phenyl]-2-hydroxy-benzamide
ID: ALA4793886
PubChem CID: 162673390
Max Phase: Preclinical
Molecular Formula: C19H12Cl3NO4
Molecular Weight: 424.67
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Nc1ccc(Oc2ccc(O)cc2)c(Cl)c1)c1cc(Cl)cc(Cl)c1O
Standard InChI: InChI=1S/C19H12Cl3NO4/c20-10-7-14(18(25)16(22)8-10)19(26)23-11-1-6-17(15(21)9-11)27-13-4-2-12(24)3-5-13/h1-9,24-25H,(H,23,26)
Standard InChI Key: MWTOGDXGFLZURM-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
2.5927 -27.8056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5935 -28.6288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3061 -29.0400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0144 -28.6250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0097 -27.7988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3005 -27.3954 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7278 -29.0350 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.4380 -28.6195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1487 -29.0339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8584 -28.6191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8557 -27.7969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1373 -27.3913 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4304 -27.8043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1490 -29.8552 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
7.5654 -27.3846 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.2793 -27.7895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9890 -27.3773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2836 -28.6109 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.6973 -27.7843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4065 -27.3727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4027 -26.5506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6837 -26.1417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9816 -26.5598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2660 -26.1535 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.6766 -25.3204 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
11.1203 -27.7780 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1.8845 -27.3979 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
9 14 1 0
11 15 1 0
15 16 1 0
16 17 1 0
16 18 2 0
17 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 17 1 0
23 24 1 0
22 25 1 0
20 26 1 0
1 27 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 424.67 | Molecular Weight (Monoisotopic): 422.9832 | AlogP: 6.10 | #Rotatable Bonds: 4 |
Polar Surface Area: 78.79 | Molecular Species: ACID | HBA: 4 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 5.95 | CX Basic pKa: ┄ | CX LogP: 5.77 | CX LogD: 4.40 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.47 | Np Likeness Score: -0.97 |
References
1. Fujii S,Kikuchi E,Watanabe Y,Suzuyama H,Ishigami-Yuasa M,Mori T,Isobe K,Uchida S,Kagechika H. (2020) Structural development of N-(4-phenoxyphenyl)benzamide derivatives as novel SPAK inhibitors blocking WNK kinase signaling., 30 (17): [PMID:32738993] [10.1016/j.bmcl.2020.127408] |